Skip to main content

Review: Creative Biolabs' Model-org Antibodies Fluorescently Labeling Services

Model organisms (Model-org) are non-human species, from which researchers can get insights into other organisms in biological research processes. Various model organism species such as zebrafish, flies, yeast, and rice, greatly contribute to the basic and clinical research in animal husbandry, fisheryagriculture, forestry, etc. Investigations on model organisms can be aided by antibody labeling when samples of interest need to be detected, isolated, or purified, though the selection of a proper label can be a challenge.

 


To select the best antibody labeling way for our Model-org project, we then found Creative Biolabs, one of the most well-established CROs for antibody development. After a comprehensive discussion and consultancy with the scientists at Creative Biolabs, fluorescent tags were suggested based on our research direction. Fluorescent labels are directly conjugated to the antibody of interest, indicating that we can directly detect the number of fluorescent signals as it should be proportional to that of target proteins in the Model-org sample.

 

As we know, the use of fluorescently labeled antibodies is increasing in detection, sorting, and microscopy imaging. Our project required non-covalent antibody labeling, and Creative Biolabs provided a wide range of label fluorescence for rapid and high-quality non-covalent antibody labeling. All these factors rendered us to order the fluorescently labeled antibody service from Creative Biolabs, which later proved to be the right choice.

 

The wide selection of labels, including enzyme marker, conventional fluorescein, Cy series of fluorescein, fluorescent double label, phycobiliproteins, and colloidal gold mark allows Creative Biolabs to label IgG antibody, macromolecular protein, small molecule polypeptide, small molecule compound, etc. in terms of the specific project need.

 

Workflow of Creative Biolabs' Fluorescently Labeling Services

 

In addition to different label options and a worldwide reputation, Creative Biolabs attracted us with its transparent and efficient workflow. The service started from acquiring the customer's fluorescent marking menu and if the researchers want to use fluorescent labels for western assays, flow cytometry, or IF for highly quantitative assays.

 

Then scientists at Creative Biolabs promptly returned us with solutions and arranged to the customized experiment, following a quick production of labeled antibodies and related reports. The ongoing process and related reports were updated to us in time.

 

Creative Biolabs also has developed conjugated antibody reagents and a broad list of model organism antibody products when clients need target labeled antibodies derived from the same model organism species but can't wait for the labeling experiment process.

 

Other Antibody Services We Discovered

 

The success of our projects encouraged us to discover more possibilities at Creative Biolabs. As a leading life science company, Model-org antibody services at Creative Biolabs are not limited to fluorescence labeling, but also include:

 

Fab abzyme cutting service that obtains antibody Fab fragments using specific proteases.

Avi-tag biotinylated antibody service to achieve the protein biotinylation in vivo or in vitro without affecting the protein's bioactivity.

 

In a word, Creative Biolabs is an important resource for Model-org services and Model-org products. We would certainly recommend this company for its high-quality work outcomes and friendly prices, hoping researchers succeed in model organism studies just like us.

Comments

Popular posts from this blog

Everything You Want to Know About Antibody Development

  Everything You Want to Know About Antibody Development   When foreign molecules, which are known as antigens, enter our body, antibodies will be released by B cells of the immune system to specifically bind to the antigens and finally clear out those “invaders”. Such a highly specific molecular recognition mechanism has inspired a variety of antibody development research and diagnostic applications nowadays, including IVD antibody development .   What is Antibody Development?   Antibody development is the process of creating and characterizing an antibody.   The timeline of developing antibodies starts from the injection of an antigen of interest into a host animal, so that the host’s immune system can detect it and generat e  the desired antibodies. Then, antibody development proceeds with finding and isolating the desired antibodies from the rest of the protein in sera.   The reset procedure of antibody development is varied as the desired antibodi...

An Overview of the Global Bispecific Antibody Therapeutics Market

  Antibod ies , a major component of adaptive immunity, play a critical role in protective and pathogenic immune responses. In r ecent years, a wide range of antibodies is discovered as candidates of cancer therapeutic agents, including the reconstructive molecules, bispecific antibodies (BsAbs).   About Bispecific Antibody   Bispecific antibodies, as its name indicates, consists of two antigen-binding sites, which can simultaneously bind two separate and unique antigens (or different epitopes of the same antigen). This structure is  typically designed to bind to two targets, one on a cancer cell and one on an immune cell, act ivating or redirecting immune effector cells with the goal of getting the immune cell to kill the cancer cell by antibody-dependent cell-mediated cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), complement-dependent cytotoxicity (CDC) and other cytotoxic mechanisms.   U nique biological and pharmacological properties, ...

Unmodified Bacteriophages Research Updates

  R ecent research conducted by researchers from Yale University is published in  Applied and Environmental Microbiology , suggesting  that natural bacteriophage, or phage, can kill dysentery-causing bacteria and reduce virulence in surviving bacteria. It's a piece   of  inspiring news as  treating dysentery has become a challenge with the rising antibiotic resistance.   Background   Shigella flexneri , the culprit causing contagious infection marked by inflammatory diarrhea and dysentery in sub-Saharan Africa and southern Asia, kills about 160,000 people globally every year. The World Health Organization (WHO) takes priority to this pathogen in terms of increasing cases, antimicrobial resistance, and limited treatment options.   S. flexneri  is active primarily in low-income countries, like southern Asia and sub-Saharan Africa. In these places, dirty drinking water is a concern causing dysentery, while antibiotics are expensive and unav...